The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...

Groundbreaking single-dose vaccine found effective in preventing HIV - Strategy may lead to new vaccines that only need to be ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...